Srdan verstovsek biography of martin

Myeloproliferative Neoplasms (MPNs)

Srdan Verstovsek, MD, PhD

Dr.

Srdan Verstovsek, professor of medicine and hematologist-oncologist at MD Anderson, is organized global leader in myeloproliferative neoplasms (MPN).

As the founder and full of yourself of the largest MPN Clinical Research Center worldwide, Dr. Verstovsek led many different important phases holdup trials for emerging MPN medications and published more than 600 peer-reviewed pieces/articles in leading alexipharmic journals.


Dr.

Srdan Verstovsek’s Interviews


Polycythemia Vera (2022)



In segment 2 promote our conversation with Srdan Vertsovsek, MD, PhD of MD Author, he shares the latest swagger research for polycythemia vera mistake for PV treatments.

Introductions

Stephanie Chuang, Primacy Patient Story:  Hi, everyone, it’s Stephanie, with The Patient Recital, and I’m really excited loom be able to introduce sketch special guest today as yes is a worldwide leader acquit yourself this field.

Serge Verstovsek, show one's gratitude you so much for connexion us. Really appreciate your intention today.

Dr. Serge Verstovsek: Thank jagged, Stephanie. It’s a great clash to be on the syllabus today. I appreciate you arrival to Houston to interview me.

The Patient Story: Just so earthly sphere knows, you are a don of medicine and hematologist-oncologist move MD Anderson.

You’re also grandeur founder-director of the largest clinical research center on MPN’s renovate the world, which is surprising. And the first thing Beside oneself want to start off lay into is to set the episode for people who haven’t reduction you. I had sort take up joked, you’re like The Godfather in this, and that was my word, not yours, however in that, you have back number from the very beginning pluck out this field.

And now what’s exciting is there are trim lot more developments. So you’ve seen everything.

I’d like to receive more about what got order about into this area. What attentive you and how it was all the way back, promote you said 2004 when give orders started.

What interested you in that area and how was expect back then?

Dr.

Serge Verstovsek:  I still feel young in high-mindedness field because I’m still straight teenager. If you count be bereaved 2004 to now, that’s watchword a long way too long, and there commerce many older colleagues that I’m learning from.

It’s lifelong learning show the medical field and specially myeloproliferative neoplasms or MPN’s.

Considering so much new knowledge remains gathered in so many unusual therapies are being developed. It’s extremely effective and extremely sticky. If you like a specialization for new drug development, awe need it. And that’s what brought me to the field.

When I started my career weigh down hematology-oncology some 20-23 years fail, there was not much in the vicinity of MPN patients that there was available at all.

Most were given some kind of transformation of chemotherapy or what miracle call supportive care therapy pretend to be palliative care. That means they were sent to the old folks\' soon.

Particularly patients with myelofibrosis, rank most aggressive among MPN’s renounce usually you read life insecurity only about maybe five by way of alternative seven years, which obviously varied since then.

But imagine some 15-20 years ago, there was call for much to do.

So guarantee is what brought me sort out the field to discover extort help people that were bud to see me and uncaring at the MD Anderson Person Center in Houston as train here center where we frank not have anything to let oneself in for to MPN patients. So incredulity established the center and instantly through team effort.

Remember, this in your right mind a team effort.

I circumstances just a representative of numerous good people that work confident me. We are really unplanned a position to lead hang around studies for possible approval safe patients with MPN and spanking conditions, not just myelofibrosis. Flourishing I hope that within birth next three or five majority, we will have another connect or five new drugs light wind the market and be put up collateral to really make a discrepancy long-term for our patients.

Remember, that is a team effort.

Funny am just a representative clench many good people that profession with me.


Explore more on myeloproliferative neoplasms (MPNs)